| 2007 JASN IMPACT FACTOR 7.111 | HOME AUTHOR INFO EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP | |||
| CURRENT ISSUE | ARCHIVES | JASN Express | ONLINE SUBMISSION | |
Supplement Article |
Dialysezentrum Schwandorf/Klinikum für Innere Medizin II, University of Regensburg, Germany
Correspondence to Dr. Stephan R. Orth, Dialysezentrum Schwandorf, Marktplatz 32, D-92421 Schwandorf, Germany. Phone: 0049-9431-71520; Fax: 0049-9431-715240; E-mail: stephan.orth{at}gmx.net
ABSTRACT. In recent years, it has become apparent that smoking has a negative impact on renal function, being one of the most important remediable renal risk factors. It has been shown clearly that the risk for high-normal urinary albumin excretion and microalbuminuria is increased in smoking compared with nonsmoking subjects of the general population. Data from the Multiple Risk Factor Intervention Trial indicate that at least in men, smoking increases the risk to reach end-stage renal failure. Smoking is particularly "nephrotoxic" in older subjects, subjects with essential hypertension, and patients with preexisting renal disease. Of interest, the magnitude of the adverse renal effect of smoking seems to be independent of the underlying renal disease. Death-censored renal graft survival is decreased in smokers, indicating that smoking also damages the renal transplant. Cessation of smoking has been shown to reduce the rate of progression of renal failure both in patients with renal disease and in patients with a renal transplant. The mechanisms of smoking-induced renal damage are only partly understood and comprise acute hemodynamic (e.g., increase in BP and presumably intraglomerular pressure) and chronic effects (e.g., endothelial cell dysfunction). Renal failure per se leads to an increased cardiovascular risk. The latter is further aggravated by smoking. Particularly, survival of smokers with diabetes on hemodialysis is abysmal.
This article has been cited by other articles:
![]() |
R. P. Obermayr, C. Temml, M. Knechtelsdorfer, G. Gutjahr, J. Kletzmayr, S. Heiss, A. Ponholzer, S. Madersbacher, R. Oberbauer, and R. Klauser-Braun Predictors of new-onset decline in kidney function in a general middle-european population Nephrol. Dial. Transplant., April 1, 2008; 23(4): 1265 - 1273. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. B. Pipkin and on behalf of The Genetics of Preeclampsia Consorti Smoking in Moderate/Severe Preeclampsia Worsens Pregnancy Outcome, but Smoking Cessation Limits the Damage Hypertension, April 1, 2008; 51(4): 1042 - 1046. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Metcalfe How does early chronic kidney disease progress?: A Background Paper prepared for the UK Consensus Conference on Early Chronic Kidney Disease Nephrol. Dial. Transplant., September 1, 2007; 22(suppl_9): ix26 - ix30. [Full Text] [PDF] |
||||
![]() |
W. F. Clark, J. J. Macnab, S. J. Chen, R. Suri, L. Moist, and A. X. Garg Evaluation of GFR Estimating Equations in the General Community: Implications for Screening Clin. J. Am. Soc. Nephrol., July 1, 2006; 1(4): 787 - 795. [Abstract] [Full Text] [PDF] |
||||
|
HOME
CURRENT ISSUE
ARCHIVES
JASN Express
ONLINE SUBMISSION
AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP |
Copyright © 2008 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673